Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal Bupivacaine for Post-Op Pain in Bariatric Surgery
NCT03196505Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Total IV and Oral Morphine Equivalents at 1 week. Started Dec 2017; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03196505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03196505.